Medical University of South Carolina
Charleston, South Carolina, 29425, United States
NCT Number: NCT00000458
This study will assess whether individuals treated with sertraline (Zoloft) and cognitive behavior therapy will experience improvement with their depression and consume less alcohol than individuals treated with a placebo and cognitive behavior therapy. This is a 12-week, random assignment, placebo-controlled, double-blind study with followup assessments 1 and 3 months after treatment.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 2
Charleston, South Carolina, 29425, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02327858
Alcohol-Related Disorders, Alcoholism
Fort McMurray, Alberta, Canada
View Trial DetailsNCT02126696
Alcohol-Related Disorders, Alcoholism
Butha-Buthe, Lesotho
View Trial DetailsNCT00338962
Alcohol-Related Disorders, Alcoholism
West Haven, Connecticut, United States
View Trial DetailsNCT00004554
Alcohol-Related Disorders, Alcoholism
Philadelphia, Pennsylvania, United States
View Trial Details